27 Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method 47
for grading the state of patients for the clinician. J Psychiatr Res
1975;12:189–98.
28 Lawton MP, Brody EM. Assessment of older people: self-maintaining and 48
instrumental activities of daily living. Gerontologist 1969;9:179–86.
29 American Psychiatric Association. Diagnostic and statistical manual of mental
disorders. 4th ed. Text revised. Washington, DC: American Psychiatric 49
Association, 2000.
30 Hachinski VC, Iliff LD, Zilhka E. Cerebral blood flow in dementia. Arch Neurol
1975;32(9):632–7. 50
31 Sorbi S, Nacmias B, Forleo P, et al. Alzheimer's disease and apolipoprotein E
in Italy. Ann N Y Acad Sci 1996;777:260–5.
32 Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer
dementia and controls by automated analysis of multicenter FDG PET. 51
Neuroimage 2002;17:302–16.
33 Chang LT. A method for attenuation correction in radionuclide computed
tomography. IEEE Trans Nucl Sci 1978;25:638–43. 52
34 Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain: 3- dimensional proportional system—an approach to cerebral imaging. New
York: Thieme, 1988.
35 Friston KJ, Frith CD, Liddle PF, et al. Comparing functional (PET) images: the 53
assessment of significant change. J Cereb Blood Flow Metab 1991;11:690–9.
36 Frackowiak RSJ, Friston KJ, Frith CD, et al. Characterising brain images with
the general linear model. In: Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ,
Mazziotta JC, eds. Human brain function. San Diego, CA: Academic Press, 54
1997:59–84.
37 Sokoloff L. Energetics of functional activation in neural tissues. Neurochem
Res 1999;24:321–9.
38 Magistretti PJ, Pellerin L, Rothman DL, et al. Energy on demand. Science 55
1999;283:496–7.
39 Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic
glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc 56
Natl Acad Sci U S A 1994;91:10625–9.
40 Rocher AB, Chapon F, Blaizot X, et al. Resting-state brain glucose utilization
as measured by PET is directly related to regional synaptophysin levels: a
study in baboons. Neuroimage 2003;20:1894–8. 57
41 Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations
in Alzheimer's disease: synapse loss is the major correlate of cognitive 58
impairment. Ann Neurol 1991;30:572–80.
42 Herholz K. PET studies in dementia. Ann Nucl Med 2003;17:79–89.
43 Lawlor BA, Ryan TM, Schmeidler J, et al. Clinical symptoms associated with 59
age at onset in Alzheimer's disease. Am J Psychiatry 1994;151:1646–9.
44 Jacobs D, Sano M, Marder K, et al. Age at onset of Alzheimer's disease: 60
relation to pattern of cognitive dysfunction and rate of decline. Neurology
1994;44:1215–20. 61
45 Mosconi L, Sorbi S, Nacmias B, et al. Age and APOE genotype interaction in
Alzheimer's disease. An FDG-PET study. Psychiatr Res Neuroimag
2004;130(2):141–50. 62
46 Braak H, Braak E. Neuropathological staging of Alzheimer-related changes.
Acta Neuropathol (Berl) 1991;82:239–59.
